Plantar focal idiopathic hyperhidrosis and botulinum toxin: A pilot study

European Journal of Dermatology

Volumn 17, Issue 1, 2007, Pages 52-54

  Campanati, Anna ^a   Bernardini, Maria Luisa ^a   Gesuita, Rosaria ^b   Offidani, Annamaria ^a  

^a Ospedale Regionale Torrette   (Italy)

^b UNIVERSITÀ POLITECNICA DELLE MARCHE   (Italy)

Author keywords

Axillary hyperhidrosis; Botulinum toxin type A; Palmar hyperhidrosis; Plantar hyperhidrosis

Indexed keywords

BOTULINUM TOXIN A;

ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; HUMAN; HYPERHIDROSIS; IDIOPATHIC DISEASE; MALE; MULTIPLE CYCLE TREATMENT; PLANTAR HYPERHIDROSIS; QUALITY OF LIFE; QUESTIONNAIRE; SWEATING; UNSPECIFIED SIDE EFFECT;

BOTULINUM TOXIN TYPE A; FEMALE; FOOT DERMATOSES; HUMANS; HYPERHIDROSIS; MALE; PILOT PROJECTS;

EID: 33847738542     PISSN: 11671122     EISSN: None     Source Type: Journal    
DOI: 10.1684/ejd.2007.0094     Document Type: Article

References (14)

1. Naver H, Aquilonius SM. The treatment of focal hyperhidrosis with botulinum toxin. Eur J Neurol 1997; 4: S75-S79.
2. Lowe N, Campanati A, Bodokh I, Cliff S, Jaen P, Kreyden O, Naumann M, Offidani A, Vadoud J, Hamm H. The place of botulinum toxin type A in the treatment of focal hyperhidrosis. Br J Dermatol 2004; 151: 1115-22.
3. Solish N, Benohanian A, Kowalski JW, Canadian Dermatology Study Group on Health-Related Quality of Life in Primary Axillary Hyperhidrosis. Prospective open-label study of botulinum toxin type A in patients with axillary hyperhidrosis: effects on functional impairment and quality of life. Dermatol Surg 2005; 31: 405-13.
4. Heckmann M, Plewig G, Hyperhidrosis Study Group. Low-dose efficacy of botulinum toxin A for axillary hyperhidrosis: a randomized, side-by-side, open-label study. Arch Dermatol 2005; 141: 1255-9.
5. Lowe NJ, Yamauchi PS, Lask GP, Patnaik R, Iyer S. Efficacy and safety of botulinum toxin type a in the treatment of palmar hyperhidrosis: a double-blind, randomized, placebo-controlled study. Dermatol Surg 2002; 28: 822-7.
6. Maillard H, Briand N, Bara C, Celerier P. Efficacy of botulinum toxin A in the treatment of axillary and palmar hyperhidrosis: 10 cases. Ann Dermatol Venereol 2003; 130: 511-3.
7. Naumann M, Hofmann U, Bergmann I, Hamm H, Toyka KV, Reiners K. Focal hyperhidrosis: effective treatment with intracutaneous botulinum toxin. Arch Dermatol 1998; 134: 301-4.
8. Naumann M, Bergmann I, Hofmann U, Hamm H, Reiners K. Botulinum toxin for focal hyperhidrosis: technical considerations and improvements in application. Br J Dermatol 1998; 139: 1123-4.
9. Vadoud-Seyedi J. Treatment of plantar hyperhidrosis with botulinum toxin type A. Int J Dermatol 2004; 43: 969-71.
10. Vadoud-Seyedi J, Simonart T, Heenen M. Treatment of plantar hyperhidrosis with dermojet injections of botulinum toxin. Dermatology 2000; 201: 179.
11. Sevim S, Dogu O, Kaleagasi H. Botulinum toxin-A therapy for palmar and plantar hyperhidrosis. Acta Neurol Belg 2002; 102: 167-70.
12. Finlay AY, Khan GK. Dermatology life quality index (DLQI) - a simple practical measure for routine clinical use. Clin Exp Dermatol 1994; 19: 210-6.
13. Mazzotti E, Picardi A, Sampogna F, Sera F, Pasquini P, Abeni D, and the Idi Multipurpose Psoriasis Research on Vital Experiences (Improve) study group. Sensitivity of the Dermatology Life Quality Index to clinical change in patients with psoriasis. Br J Dermatol 2003; 149: 318-22.
14. Finlay AY. Current severe psoriasis and the Rule of Tens. Br J Dermatol 2005; 152: 861-7.